These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29100326)

  • 1. Fiber-modified hexon-chimeric oncolytic adenovirus targeting cancer associated fibroblasts inhibits tumor growth in gastric carcinoma.
    Pang T; Wang X; Gao J; Chen W; Shen XJ; Nie MM; Luo T; Yin K; Fang G; Wang KX; Xue XC
    Oncotarget; 2017 Sep; 8(44):76468-76478. PubMed ID: 29100326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
    Wang H; Wei F; Li H; Ji X; Li S; Chen X
    Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma.
    Chen W; Wu Y; Liu W; Wang G; Wang X; Yang Y; Chen W; Tai Y; Lu M; Qian Q; Zhang Q; Chen G
    Cancer Lett; 2011 Aug; 307(1):93-103. PubMed ID: 21504839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager.
    de Sostoa J; Fajardo CA; Moreno R; Ramos MD; Farrera-Sal M; Alemany R
    J Immunother Cancer; 2019 Jan; 7(1):19. PubMed ID: 30683154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma.
    Li M; Li G; Kiyokawa J; Tirmizi Z; Richardson LG; Ning J; Das S; Martuza RL; Stemmer-Rachamimov A; Rabkin SD; Wakimoto H
    Acta Neuropathol Commun; 2020 Dec; 8(1):221. PubMed ID: 33308315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells.
    Li LX; Zhang YL; Zhou L; Ke ML; Chen JM; Fu X; Ye CL; Wu JX; Liu RY; Huang W
    J Transl Med; 2013 Oct; 11():257. PubMed ID: 24124726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
    Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
    Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced antitumor efficacy of fiber-modified, midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma.
    Takagi-Kimura M; Yamano T; Tamamoto A; Okamura N; Okamura H; Hashimoto-Tamaoki T; Tagawa M; Kasahara N; Kubo S
    Cancer Sci; 2013 Nov; 104(11):1433-9. PubMed ID: 23962292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers.
    Wakayama M; Abei M; Kawashima R; Seo E; Fukuda K; Ugai H; Murata T; Tanaka N; Hyodo I; Hamada H; Yokoyama KK
    Clin Cancer Res; 2007 May; 13(10):3043-50. PubMed ID: 17505007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor β Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models.
    Xu W; Yang Y; Hu Z; Head M; Mangold KA; Sullivan M; Wang E; Saha P; Gulukota K; Helseth DL; Guise T; Prabhkar BS; Kaul K; Schreiber H; Seth P
    Hum Gene Ther; 2020 Aug; 31(15-16):863-880. PubMed ID: 32394753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel oncolytic adenovirus based on simian adenovirus serotype 24.
    Cheng T; Song Y; Zhang Y; Zhang C; Yin J; Chi Y; Zhou D
    Oncotarget; 2017 Apr; 8(16):26871-26885. PubMed ID: 28460470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.
    Wang RF; Zhang LH; Shan LH; Sun WG; Chai CC; Wu HM; Ibla JC; Wang LF; Liu JR
    Exp Mol Pathol; 2013 Dec; 95(3):350-56. PubMed ID: 24422232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX.
    Stepanenko AA; Chekhonin VP
    Virus Res; 2018 Sep; 257():40-51. PubMed ID: 30125593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
    Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
    Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined oncolytic adenovirus carrying MnSOD and mK5 genes both regulated by survivin promoter has a synergistic inhibitory effect on gastric cancer.
    Liu SS; Hu JQ; Gu JF; Ni AM; Tang WH; Liu XY
    Neoplasma; 2022 Jan; 69(1):36-48. PubMed ID: 34881625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells.
    Chen L; Chen D; Gong M; Na M; Li L; Wu H; Jiang L; Qian Y; Fang G; Xue X
    Cancer Lett; 2009 Nov; 284(2):141-8. PubMed ID: 19447545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy.
    Short JJ; Rivera AA; Wu H; Walter MR; Yamamoto M; Mathis JM; Curiel DT
    Mol Cancer Ther; 2010 Sep; 9(9):2536-44. PubMed ID: 20736345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay of Helicobacter pylori, fibroblasts, and cancer cells induces fibroblast activation and serpin E1 expression by cancer cells to promote gastric tumorigenesis.
    Chen X; Chen W; Zhao Y; Wang Q; Wang W; Xiang Y; Yuan H; Xie Y; Zhou J
    J Transl Med; 2022 Jul; 20(1):322. PubMed ID: 35864535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro primary cell culture as a physiologically relevant method for preclinical testing of human oncolytic adenovirus.
    Adamson RE; Frazier AA; Evans H; Chambers KF; Schenk E; Essand M; Birnie R; Mitry RR; Dhawan A; Maitland NJ
    Hum Gene Ther; 2012 Feb; 23(2):218-30. PubMed ID: 21823897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumor injection of oncolytic adenovirus expressing HSP70 prolonged survival in melanoma B16 bearing mice by enhanced immune response.
    Ren Z; Ye X; Fang C; Lu Q; Zhao Y; Liu F; Liang M; Hu F; Chen HZ
    Cancer Biol Ther; 2008 Feb; 7(2):191-95. PubMed ID: 18073525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.